RPg Family Wealth Advisory LLC Invests $31,000 in McKesson Co. (NYSE:MCK)

RPg Family Wealth Advisory LLC purchased a new stake in McKesson Co. (NYSE:MCK) during the 3rd quarter, HoldingsChannel reports. The firm purchased 62 shares of the company’s stock, valued at approximately $31,000.

Other institutional investors also recently added to or reduced their stakes in the company. CreativeOne Wealth LLC raised its holdings in McKesson by 5.8% in the 3rd quarter. CreativeOne Wealth LLC now owns 6,613 shares of the company’s stock valued at $3,270,000 after acquiring an additional 364 shares in the last quarter. BNP Paribas lifted its stake in McKesson by 252.1% during the third quarter. BNP Paribas now owns 46,107 shares of the company’s stock worth $22,716,000 after purchasing an additional 33,012 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its stake in McKesson by 20.4% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 554 shares of the company’s stock worth $274,000 after buying an additional 94 shares during the last quarter. Blueshift Asset Management LLC acquired a new position in shares of McKesson in the 3rd quarter worth approximately $1,413,000. Finally, Cynosure Group LLC increased its holdings in McKesson by 151.5% during the 3rd quarter. Cynosure Group LLC now owns 1,597 shares of the company’s stock valued at $790,000 after purchasing an additional 962 shares in the last quarter. 85.07% of the stock is owned by institutional investors.

McKesson Stock Up 0.2 %

NYSE MCK opened at $626.54 on Thursday. The company has a market cap of $79.53 billion, a PE ratio of 32.45, a price-to-earnings-growth ratio of 1.33 and a beta of 0.44. The firm’s 50-day simple moving average is $537.43 and its two-hundred day simple moving average is $558.92. McKesson Co. has a 52 week low of $431.35 and a 52 week high of $637.51.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $7.07 EPS for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The business had revenue of $93.65 billion for the quarter, compared to analysts’ expectations of $89.33 billion. During the same period last year, the business earned $6.23 earnings per share. The business’s quarterly revenue was up 21.3% on a year-over-year basis. As a group, equities research analysts anticipate that McKesson Co. will post 32.78 EPS for the current year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd will be given a $0.71 dividend. The ex-dividend date is Monday, December 2nd. This represents a $2.84 annualized dividend and a dividend yield of 0.45%. McKesson’s dividend payout ratio is 14.71%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on MCK shares. Deutsche Bank Aktiengesellschaft dropped their price target on shares of McKesson from $623.00 to $579.00 and set a “buy” rating for the company in a research note on Wednesday, September 25th. Citigroup raised their price target on McKesson from $630.00 to $713.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Mizuho upped their price objective on McKesson from $540.00 to $570.00 and gave the company a “neutral” rating in a report on Thursday, August 8th. Evercore ISI upped their price target on McKesson from $560.00 to $680.00 and gave the company an “outperform” rating in a research note on Thursday, November 7th. Finally, JPMorgan Chase & Co. upped their price target on shares of McKesson from $656.00 to $661.00 and gave the company an “overweight” rating in a report on Wednesday, August 21st. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, McKesson currently has a consensus rating of “Moderate Buy” and a consensus price target of $631.57.

Insider Activity

In other news, CEO Brian S. Tyler sold 3,753 shares of the stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the completion of the transaction, the chief executive officer now owns 78,586 shares of the company’s stock, valued at approximately $44,094,604.60. This represents a 4.56 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.11% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.